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SUMMARY 
Schmallenberg virus was discovered in North Rhine-Westphalia in Germany in 2011. The virus spread 
over most of Europe during the following years, including United Kingdom and the Nordic countries. 
Its origins are yet to be discovered. Schmallenberg virus belongs to the Simbu serogroup of the 
Bunyaviridae family, genus Orthobunyavirus. Where, exactly, on the phylogenetic tree of Simbu 
serogroup viruses it should be placed is not concluded, but its closest relatives seem to be Shamonda 
virus, Aino virus, Akabane virus and Sathuperi virus. 
 
The susceptible species are primarily ruminants, but Schmallenberg virus and its antibodies have 
occasionally been found in dogs. No evidence of zoonotic potential has been found. The virus is mainly 
transmitted by different species of biting midges of the genus Culicoides. Transplacental transmission 
can occur during the early part of pregnancy in ruminants, after placentomes have been formed. 
Infectious Schmallenberg virus has also been found to be shed in semen of cattle and sheep, thus 
horizontal transmission is possible in theory but has not yet been proven experimentally. 
 
Clinical symptoms in adult cattle, sheep and goats are usually mild or absent, lasts only a few days and 
includes fever, reduced milk yield and diarrhoea. Transplacental transmission can, but does not always, 
lead to congenital Schmallenberg. If it does, the most common symptoms are malformations such as 
arthrogryposis (joint deformity/contracture) and different malformations of the vertebral column and 
brain. Reduced body weight in affected calves at birth seems to be correlated to the severity of the 
malformations. Infected foetuses are sometimes aborted or stillborn. 
 
Schmallenberg virus antibodies are detectable by indirect methods such as ELISA and virus 
neutralization test. Cross reactions with antibodies directed against other viruses of the Simbu serogroup 
are known to occur. In the present study, seroprevalence for Schmallenberg virus in the Gaza province 
in southern Mozambique was investigated in cattle, sheep and goats, using competitive Schmallenberg 
ELISA. The overall seroprevalence in cattle was approximately 90 %, in sheep close to 60 % and almost 
75 % in goats. All investigated herds and flocks had seropositive animals. 
 
Detection of Schmallenberg viral RNA is possible by real-time RT-PCR, either specific for just 
Schmallenberg virus, or a general pan-Simbu real-time RT-PCR. Some samples in the present study that 
were positive in competitive ELISA were analysed using pan-Simbu real-time RT-qPCR. None of the 
included samples gave a positive result in the PCR. 
 
The findings in this study show that antibodies able to produce a positive result in Schmallenberg virus 
ELISA circulates the Gaza province in Mozambique. The virus responsible for the positive results might 
be Schmallenberg virus, but it can as well be one or many other Simbu serogroup viruses. Cross 
reactivity cannot be ruled out, but is on the contrary quite possible, since other members of the Simbu 
serogroup are known to circulate in Africa. 
 
Further studies in Mozambique, or other parts of southern Africa, would be of interest to determine 
which virus or viruses that are causing the positive ELISA results. Virus neutralization tests can be used 
to investigate which Simbu serogroup virus or viruses that are circulating the area. Schmallenberg virus 
and Simbu serogroup virus detection is of even greater interest, but this might prove difficult due to the 
short viremic period of Schmallenberg virus and other Simbu serogroup viruses. Since Schmallenberg 
virus shedding in semen can continue for more than two months in some individuals, virus detection in 
semen might be a viable way. Virus detection in the vector can also be possible to achieve, especially if 
very many biting midges are included.  
    
 
SAMMANFATTNING 
Schmallenbergviruset upptäcktes i Nordrhein-Westfalen i Tyskland år 2011. Det spred sig över Europa, 
inklusive Storbritannien och Norden, under de följande åren. Var viruset ursprungligen kom ifrån är 
ännu okänt. Schmallenbergvirus tillhör Simbu-serogruppen i familjen Bunyaviridae, genus 
Orthobunyavirus, men exakt var på det fylogenetiska trädet det ska placeras in är ännu inte helt klarlagt. 
Dess närmsta släktingar tycks vara Shamondavirus, Ainovirus, Akabanevirus och Sathuperivirus. 
 
Mottagliga djurslag är framför allt idisslare, men Schmallenbergvirus och antikroppar riktade mot 
viruset har påträffats även hos hundar. Det finns inga indikationer på att viruset har någon zoonotisk 
potential. Huvudsakligen överförs Schmallenbergvirus genom olika arter av svidknott, tillhörande 
genuset Culicoides. Transplacental överföring av viruset kan ske under tidig dräktighet hos idisslare, 
efter att placentomen har bildats. Infektiöst Schmallenbergvirus har också påträffats i sperma från tjur 
och bagge och viruset skulle därför i teorin kunna överföras horisontellt vid parning. Detta har dock inte 
påvisats experimentellt ännu. 
 
Nöt, får och getter visar vanligtvis milda eller inga kliniska symptom vid smitta. Symptomen kan 
innefatta feber, minskad mjölkproduktion och diarré hos vuxna djur. Transplacental överföring kan, men 
behöver inte, resultera i kongenital Schmallenberg. De vanligaste symptomen hos intrauterint smittade 
kalvar, lamm och killingar är arthrogryposis (ledmissbildningar och ledkontrakturer) och missbildningar 
i ryggraden och hjärnan. Lägre födselvikt hos smittade kalvar tycks korrespondera med gravare 
missbildningar. Infekterade foster kan även aborteras eller vara dödfödda. 
 
Indirekta metoder såsom ELISA och virusneutraliseringstest kan användas för att detektera antikroppar 
mot Schmallenbergvirus. Det är känt att korsreaktioner med antikroppar riktade mot andra virus i 
Simbu-serogruppen kan förekomma. I denna studie har seroprevalensen för antikroppar hos kor, får och 
getter i Gazaprovinsen i Moçambique undersökts med Schmallenberg-ELISA. Seroprevalensen hos 
samtliga undersökta kor var ungefär 90 %, hos får nära 60 % och strax under 75 % hos getter. Alla 
undersökta besättningar hade seropositiva djur. 
 
Det är möjligt att hitta Schmallenbergvirus-RNA med hjälp av realtids-RT-PCR, antingen specifik för 
Schmallenbergvirus eller en mer generaliserad realtids-RT-PCR som inkluderar flera virus ur Simbu-
serogruppen. Vissa av de ELISA-positiva proverna i denna studie analyserades med hjälp av pan-Simbu 
realtids-RT-qPCR, men inget prov gav positivt utslag för något Simbuvirus. 
 
Resultatet av denna studie bekräftar att antikroppar, som kan ge positivt utslag i Schmallenberg- ELISA, 
cirkulerar i Gazaprovinsen i Moçambique. Viruset som föranlett detta antikroppssvar kan vara 
Schmallenbergvirus, men det kan lika gärna vara orsakat av ett eller flera andra Simbuvirus. 
Korsreaktivitet kan inte uteslutas, utan är tvärtom ganska sannolik, eftersom det är välkänt att andra 
virus ur Simbu-serogruppen cirkulerar i Afrika. 
 
Vidare studier i Moçambique eller andra delar av södra Afrika är av intresse för att kunna undersöka 
vilket eller vilka virus som orsakat det positiva ELISA-resultatet. För att undersöka vilka Simbuvirus 
som finns i området kan virusneutraliseringstest användas. Att upptäcka RNA från Schmallenbergvirus 
eller andra Simbuvirus är av ännu större intresse, men detta kan visa sig vara svårt att uppnå med tanke 
på den korta viremiperioden som dessa ger upphov till. Eftersom Schmallenbergvirus utsöndras i sperma 
i mer än två månader hos vissa individer kan virusdetektion i sperma kanske vara en möjlig väg. 
Virusdetektion i vektorn är också en möjlighet, särskilt om det går att inkludera ett stort antal svidknott 
i en sådan studie. 
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INTRODUCTION 
In 2011, Schmallenberg virus was discovered in North Rhine-Westphalia in Germany, Europe, 
(Hoffman et al., 2012) and it became endemic on the continent during the following years 
(EFSA, 2012b, 2013). The origin of the virus is shrouded in mystery. In this master thesis, there 
were three major aims: 
 
The first one was to introduce Schmallenberg virus and summarize what research has concluded 
about the virus since its introduction in Europe. 
 
The second one was to screen cattle, sheep and goats in the Gaza Province in Mozambique for 
Schmallenberg virus antibodies. The southern parts of Africa have been pointed out as a hotspot 
for emerging infectious diseases and a previous screening study in 2013 (Blomström et al., 
2014) has shown a great abundance of animals positive in Schmallenberg competitive ELISA 
in the Zambezia province in Mozambique. 
 
The third one was to detect viral RNA from viruses in the Simbu serogroup from possibly 
infected animals in the Gaza province in Mozambique, thus providing evidence that one or 
many Simbu serogroup viruses are present in the area. 
 
LITTERATURE REVIEW 
Discovery of Schmallenberg virus 
During the summer and autumn of 2011, reports of a mild clinical disease including fever, 
diarrhoea and decreased milk production started coming from North Rhine-Westphalia in 
Germany and the Netherlands (Hoffman et al., 2012). All infectious agents known to cause this 
kind of symptoms were ruled out and blood samples from infected animals were analysed using 
metagenomics, only to discover a previously unknown virus belonging to the Simbu serogroup 
of the Bunyaviridae family, genus Orthobunyavirus. The virus was named Schmallenberg virus 
after the geographical location where it was originally discovered (Hoffman et al., 2012). 
Orthobunyaviruses of the Simbu serogroup had until then not been known to be prevalent in 
Europe at all, though widely spread in the rest of the world (Saeed et al., 2001). 
 
Phylogeny 
Shortly after discovery, Hoffman et al. (2012) sequenced the complete genome of the new virus 
and found it belonged to the genus Orthobunyavirus. The small (830 nucleotides), medium 
(4415 nucleotides) and large (6865 nucleotides) segments were compared to other 
Orthobunyaviruses and it was discovered that the S segment most resembled Shamonda virus, 
detected in Japanese cattle, with a similarity of 97 %. The M segment resembled Aino virus, 
found in Japanese cattle, to an extent of 71 % and the L segment was similar by 69 % to Akabane 
virus, also found in Japanese cattle. Based on these findings, Schmallenberg virus was classified 
as a Shamonda-like virus in the Simbu serogroup of genus Orthobunyavirus, family 
Bunyaviridae (Hoffman et al., 2012).  However, Yanase et al. (2012) suggested that 
Schmallenberg virus is a reassortant virus with the S and L segments originating from 
Shamonda virus and the M segment originating from Sathuperi virus. 
 
Goller et al. (2012) concluded that Schmallenberg virus belongs to the species Sathuperi virus 
and most likely is not a reassortant virus and in fact may be an ancestor to Shamonda virus (and 
not the other way around as previously suspected). The similarities between Shamonda and 
Schmallenberg virus is explained by Shamonda virus being a reassortant between 
Schmallenberg virus (S and L segments) and another unknown virus (M segment). 
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Detection tools and cross reactivity 
Commercial kits are available for detection of Schmallenberg virus antibodies in multi-species 
serum/plasma and milk by indirect ELISA. Detection kits for Schmallenberg virus antibodies 
in multi-species serum/plasma by competitive ELISA are also available (ID vet, 2017). Very 
high specificity has been shown for indirect ELISA when compared to virus neutralization tests 
in a European study (Bréard et al., 2013). Using virus neutralization tests to determine presence 
or absence of antibodies is generally considered as “gold standard” and can of course also be 
used. 
 
In a study by Mathew et al. (2015) in Tanzania, cattle serum samples that were positive in 
indirect Schmallenberg virus ELISA were tested using Simbu serogroup virus neutralization 
tests for ten different Simbu serogroup viruses. All tested samples were positive for one or more 
of the viruses included, and only a few had the highest titer for Schmallenberg virus. In some 
of the samples, high titers could be seen for one or more viruses and low titers for one or more 
other viruses. This suggests that members of the Simbu serogroup is prone to cross react and 
may confuse the interpretation of indirect detection methods like ELISA and virus 
neutralization tests. 
 
Another study in Jordan used indirect Schmallenberg virus ELISA to investigate the prevalence 
in serum from cattle, sheep and goats and bulk milk from cattle. Positive results were obtained 
from some of the samples and a virus neutralization test was done. The results suggested that it 
was not Schmallenberg virus antibodies responsible for the positive result, but instead Aino 
virus antibodies (Abutarbush et al., 2015). 
 
Direct detection of Schmallenberg virus is possible using real-time RT-PCR. Protocols 
exclusively designed to detect Schmallenberg virus are available, as well as a protocol for 
detection of multiple viruses from the Simbu serogroup (Fischer et al., 2013). 
 
Geographical distribution 
Europe 
It is quite certain that the virus was not prevalent, or at least only prevalent to a very low extent, 
in the core area of the outbreak before summer 2011, since samples from Belgium and Germany 
collected in 2010 and spring and summer 2011 were negative in serological tests (Garigliany et 
al., 2012; Wernike et al., 2013c). 
 
Schmallenberg virus spread in the southern parts of Belgium during the second half of 2011 
(Garigliany et al., 2012), and in spring 2012 it was considered endemic in the country with a 
seroprevalence of approximately 90 % in cattle (Méroc et al., 2013; Wernike et al., 2014a), 
almost 85 % in sheep and slightly above 40 % in goats (Méroc et al., 2014). In winter 2012, the 
seroprevalence in the Netherlands was above 70 % in cattle, with the highest within-herd 
seroprevalence seen in herds in the central and eastern parts of the country (Wernike et al., 
2014a). Germany showed a spatial pattern of spread during winter 2011 and spring 2012 of 
higher seroprevalence in the regions closest to the core area of the Schmallenberg virus outbreak 
in the north-western part of the country, and lower in the counties in eastern and south-eastern 
parts. The seroprevalence in Germany, all counties included, among cattle, sheep and goats was 
61 %, 24.7 % and 26.4 % respectively during winter 2011 and spring 2012. The seroprevalence 
in North Rhine-Westphalia, where the community of Schmallenberg is located, was almost 98 
% in cattle (Wernike et al., 2014a).               
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The outbreak in northern France started in cattle in September-October 2011 and spread to 
sheep and goats in the northern parts of France during autumn 2011 and the southern parts of 
the country during spring 2012. During January 2012, the first cases of congenital 
Schmallenberg were reported in lambs, goat kids and calves in the North-Eastern part of the 
country (Dominguez et al., 2014). About two years after its discovery in 2011, Schmallenberg 
virus had already spread over most of Europe including United Kingdom, except Scotland, and 
the Nordic countries, except Iceland (EFSA 2012b, 2013). Serological tests in cattle and sheep 
as far east as Romania were positive during autumn 2013 (Danes et al., 2014). 
 
Reports of possible recirculation of Schmallenberg Virus after the initial epidemic in 2011-
2013 have come from many countries, including Germany (Wernike et al., 2015a), Belgium 
(Delooz et al., 2016), England, Wales (APHA, 2017b) and Ireland (Collins et al., 2016). In 
April 2017, Schmallenberg virus was confirmed for the first time in sheep flocks in Scotland in 
April 2017 (APHA, 2017a), possibly a result of recirculation in southern United Kingdom and 
Ireland. Many animals in Europe today have not been exposed to infection or vaccine, i.e. 
seroprevalence is decreasing (Wernike et al., 2015b). Recirculation, though not as economically 
costly as the introduction of Schmallenberg virus in 2011, may occur. 
 
Nordic countries 
Schmallenberg viral RNA was isolated, using RT-PCR, from midges from one collection site 
close to the German border in Denmark in 2011 (Rasmussen et al., 2012). In 2012, viral RNA 
was isolated from midges collected in four sampling spread over the country. Hence, the spread 
of Schmallenberg virus in Denmark mainly took place during the vector season of 2012 
(Rasmussen et al, 2013). 
 
Serological surveys and bulk milk surveys in Sweden shows that Schmallenberg virus spread 
in cattle and sheep herds mainly during the vector season of 2012, a year later than in central 
Europe. After the vector season of 2012, lasting less than four months, almost 75 % of the 
investigated bulk milk samples were ELISA positive. The first positive serological sample from 
sheep and bulk milk from cattle was both found in the county of Blekinge in south eastern 
Sweden and was collected before the vector season of 2012. The first case of congenital 
Schmallenberg in an aborted lamb was confirmed in the county of Halland in November 2012. 
RT-PCR confirmed the presence of viral RNA from malformed and/or aborted offspring of 
cattle and sheep during winter 2012-2013 (Chenais et al., 2013). Schmallenberg virus 
antibodies has been found as far north as Piteå, at latitude 65.2°, only 320 km south of the 
northern polar circle in Sweden (Chenais et al., 2013). 
 
The spread of Schmallenberg virus in Norway seems to have been limited compared to Sweden 
and Denmark. It was shown to circulate in the south-eastern parts of the country during the 
vector season of 2012. Serological surveillance showed negative results in the northern and 
western parts of the country (Åkerstedt et al., 2015). The first case of congenital Schmallenberg 
was detected in April 2013 in a calf (Wisløff et al., 2014). No evidence of Schmallenberg virus 
circulation could be found in midges during 2013 (Åkerstedt et al., 2015). 
 
In Finland, Schmallenberg virus antibodies were found in the southern parts of the country in 
August 2012 (Chenais et al., 2014). Schmallenberg virus antibodies could be found in 39 % of 
the tested dairy herds in spring 2013 (Chenais et al., 2014; Evira, 2016). 
 
Southern Africa 
If Schmallenberg virus is present in countries outside Europe is presently unknown, however, 
serological studies using ELISA and virus neutralization tests, as presented below, have shown 
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antibody positive results. Since members of the Simbu serogroup are known to circulate in 
many parts of Africa (Theodoridis et al., 1979; Zeller & Bouloy, 2000; Mathew et al., 2015) 
and because of the issue with cross reactivity, as discussed above, Blomström et al. (2013) and 
Mathew et al. (2015) concluded that the seropositive ELISA results could be caused by other 
members of the Simbu serogroup rather than by Schmallenberg virus. 
 
South Africa 
Leask et al. (2013) hypothesized that Schmallenberg virus might be a possible cause of a few 
stillborn and deformed lambs in South Africa in 2006 and 2008. In 2006, two lambs from the 
same ewe were born with deformities consistent with congenital Schmallenberg, but no further 
investigation was made. In 2008, six lambs from the same flock with 50 pregnant ewes were 
either stillborn or had Schmallenberg-like deformities. All teratogenic infectious agents known 
to circulate the area were ruled out through testing, except Rift valley fever. Rift valley fever 
was not tested due to lack of signs of liver pathology in the lambs. Since Schmallenberg virus 
was not yet known, hence it was not tested for. Leask et al. (2013) suggested based on these 
findings that Schmallenberg virus may have circulated in South Africa already in 2006 or 2008. 
Unfortunately, this thesis could not be tested, since there no longer were any samples available 
from the affected animals.  
 
Mozambique 
In 2013, a screening study for Schmallenberg virus antibodies using competitive ELISA in 
cattle, sheep and goats took place in the Zambezia province in Mozambique. Seropositive 
animals were found in all herds on all farms. 100 % of the cattle tested were positive and with 
serum 8x diluted 87 % remained positive. For sheep, the within-herd seroprevalence varied 
between 43-97 % with 71 % remaining positive when diluted 8x. The within-herd 
seroprevalence for goats varied between 72-100 % (Blomström et al., 2014). 
 
None of the farmers had observed any clinical signs of Schmallenberg virus in any of the 
animals or their offspring. Blomström et al. (2014) drew the conclusion that vector activity is 
evenly distributed because of the humid and warm climate, hence making the exposure of a 
vector borne virus/viruses, possibly causing the positive result, continuous. 
 
Tanzania 
A screening study of cattle serum from samples collected 2008-2009 and 2012-2013 in 
Tanzania has been made, using indirect ELISA for Schmallenberg virus antibodies. In the 
samples from 2008-2009, 55 % gave a positive result. Of the samples from 2012-2013, 61 % 
were positive, and 87 % of the herds investigated in 2012-2013 had at least one ELISA positive 
animal (Mathew et al., 2015). 
 
Some of the ELISA positive samples were tested by virus neutralization test. Of the samples 
from 2012-2013, 51 % were positive and of the samples from 2008-2009, 21 % were positive 
(Mathew et al., 2015). 
 
Epidemiology 
Susceptible species 
Schmallenberg virus antibodies have been found in serum in several ruminant species, 
including alpaca, anatolian water buffalo, elk, bison, red deer, fallow deer, roe deer, muntjac, 
chamois, domestic cattle, sheep and goats. Schmallenberg viral RNA has been confirmed in 
cattle, goats and sheep infected both naturally and experimentally (EFSA, 2012a). 
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Dogs living in areas where Schmallenberg virus is known to circulate have been found positive 
for Schmallenberg virus antibodies in serological tests (Johansson Wensman et al., 2013; 
Salieau et al., 2013) and in one case Schmallenberg viral RNA has been isolated from the 
cerebellum of a dog expressing neurological symptoms (Salieau et al., 2013). 
 
Zoonotic potential 
Hoffman et al. (2012) suggested that the risk of zoonotic transmission of Schmallenberg was 
“very low to negligible” due to the presumed close relationship to Shamonda virus and the 
absence of reports of clinical signs in humans. 
 
Further investigation of humans exposed to the virus through infected animals, aborted material 
and vectors was done through surveys during 2012. Molecular and serological tests were also 
conducted. None of the studies found any seropositive human blood samples or any other 
evidence of transmission to humans. The public health risk was hence deemed extremely low 
or non-existent (Ducomble et al., 2012; Reusken et al., 2012; ECDC, 2017). 
 
Transmission 
Vector 
Biting midges have been found to act as vectors for Schmallenberg virus. Especially members 
of the Culicoides obsoletus complex, but also other Culicoides spp. seems to be able to transmit 
Schmallenberg virus (De Regge et al., 2012; Rasmussen et al., 2012; Elbers et al., 2013; 
Rasmussen et al., 2013; Balenghien et al., 2014). 
 
Culicoides midges seems to prefer cattle stables over horse stables. A greater diversity of 
Culicoides species and a greater number of specimens have been found in cattle stables than in 
horse dittos, but if this is due to the cattle themselves or preferences for temperature, breeding 
sites or some other unknown factor is not yet concluded (Kameke et al., 2017). 
 
During winter, vector activity is probably absent in central and northern Europe. Domiguez et 
al. (2014) saw a clear connection between the number of reported cases of congenital 
Schmallenberg in France during 2011-2013 and the seasonality in midges. Kameke et al. (2017) 
showed that the first Culicoides midges for the season can be found inside cattle stables and 
sheep barns in mid-March in Germany. 
 
A German study found no evidence that mosquitoes can act as a vector for Schmallenberg virus. 
Approximately 50 000 specimens, mainly of the species Culex pipens/torrentium and Aedes 
vexans were collected in Schmallenberg virus abundant areas of Germany in 2011 and tested 
negative in a Schmallenberg virus specific real-time PCR (Wernike et al., 2014b). 
 
Vertical 
Schmallenberg virus can cross the placenta in cattle and infect the foetus as soon as the first 
placentome is formed, at day 30 post conception. The age of the foetus at the time of infection 
impacts the clinical outcome. Infection between day 120-150 and later of pregnancy in cows 
will likely not produce an affected offspring, since the foetus already is immunocompetent and 
can prevent the virus from spreading. This leaves a window between day 30 and 120-150 in 
cattle during which infection can be obtained and may result in a calf born with congenital 
Schmallenberg (Bayrou et al., 2014). Experiments with inoculation of Schmallenberg virus in 
pregnant ewes at day 45 and day 60 post conception resulted in colonization of the placentomes 
and transmission of Schmallenberg virus to the foetus, although the study found no clinical 
disease in the lambs born (Martinelle et al., 2015).  
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Garigliany et al. (2012) concluded that based on data from the outbreak in southern Belgium 
2011-2012, the risk of transplacental infection in an immunologically naïve herd of cattle was 
28 %. 
 
Horizontal 
Experimental subcutaneous injection of cattle (Hoffman et al., 2012; Wernike et al., 2013a), 
sheep (Wernike et al.¸2013b; Martinelle et al., 2017) and goats (Laloy et al., 2015), as well as 
intradermal injection of sheep (Martinelle et al., 2017) and intravenous (Hoffman et al., 2012) 
injection of cattle with Schmallenberg virus results in viremia in the inoculated animals. 
 
Intramuscular injection (Wernike et al., 2013b) and intradermal inoculation (Martinelle et al., 
2017) of sheep has been tried experimentally without causing viremia, but the former has 
nevertheless managed to seroconvert some of the individuals (Wernike et al., 2013b). 
 
Oral transmission has been tried experimentally in cattle, but no Schmallenberg viral RNA 
could be detected in the blood for several weeks after inoculation and the animals did not 
seroconvert (Wernike et al., 2013a). 
 
Semen 
Schmallenberg viral RNA has been found in bovine semen (Hoffman et al., 2013; Kesik-
Maliszewska & Larska, 2016; Ponsart et al., 2014; Van der Poel et al., 2013). In some 
individuals, excretion is intermittent (Hoffman et al., 2013). Laloy et al. (2015) investigated 
the semen of two experimentally infected bucks, but did not find any Schmallenberg viral RNA. 
 
Schmallenberg viral RNA has been detected both in seminal plasma and in the seminal cell 
fraction of bulls (Hoffman et al., 2013; Van der Poel et al., 2013). The highest concentrations 
of viral RNA in bull semen can be found during the first week of infection (Van der Poel et al., 
2013). Shedding of Schmallenberg viral RNA in bull semen has been shown to continue for 2-
3 months after the viremia has ended, but the period of excretion varies a lot between 
individuals (Hoffman et al., 2013; Ponsart et al., 2014). 
 
Schmallenberg viral RNA-positive semen has been proven to be infectious by subcutaneous 
injection in cattle. Venereal transmission of the virus has not yet been evaluated, but it has been 
theorized that dams might be exposed for infection through lesions caused by artificial 
insemination (Schulz et al., 2014). Ponsart et al. (2014), succeeded to inoculate and seroconvert 
mice with infected semen from bulls that had already seroconverted, thus showing that semen 
can keep its infectivity even if an immune response has taken place in the host. 
 
Pathogenesis 
The complete pathogenesis of Schmallenberg virus is not yet known. It has been shown to target 
and replicate in neurons in the developing brain and central nervous system of in utero infected 
calves and lambs, leading to cavitary lesions. In experimentally infected mice, the white matter 
in the brain of baby mice undergoes vacuolar changes when infected. In the spine, it is instead 
the grey matter that is targeted (Varela et al., 2013). 
 
Viremia 
Hoffman et al. (2012) inoculated calves with a virus isolate and discovered their blood was 
PCR-positive between day 2 and 5 post inoculation. This result has been repeated multiple times 
following inoculation in Schmallenberg antibody naïve cattle, showing a short viremic period 
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of 2-4 days, starting at day 2-6 post infection (Van der Poel et al., 2013; Wernike et al., 2013a; 
Schulz et al., 2014). 
 
A viremic period of 3-5 days, starting at day 2-7 post infection, has been reported in 
experimentally infected sheep (Wernike et al., 2013b; Poskin et al., 2014; Martinelle et al., 
2015; Poskin et al., 2015). It has also been concluded that a higher infection dose is more likely 
to infect an animal than a lower dose, but does not extend the time of viremia (Poskin et al., 
2014). 
 
The viremic period in goats is also short, 3-4 days, and starts between day 1 and 3 post infection 
(Laloy et al., 2015). 
 
Immune response and immunity 
An innate immune response has been shown to occur immediately post infection in cattle 
(Wernike et al., 2013a). Seroconversion, i.e. occurrence of Schmallenberg virus specific 
antibodies in blood, in infected cattle takes place at day 8-14 post infection (Wernike et al., 
2013a; Schulz et al., 2014). In sheep, seroconversion happens at day 6-22 post infection 
(Wernike et al., 2013b; Poskin et al., 2014; Poskin et al., 2015) and in goats between day 7-14 
post infection (Laloy et al., 2015). 
 
According to Wernike et al. (2013a), immunity lasted for at least eight weeks in experimentally 
infected cattle. A long-term study was done in Germany between 2011 and 2014, showing that 
90 % of the tested cattle still were seropositive for Schmallenberg virus antibodies after three 
years, thus concluding that a long lasting, but not lifelong, immunity can be expected (Wernike 
et al., 2015b). During experimental conditions, immunity in sheep has been shown to last for 
at least 15 months (Poskin et al., 2015). 
 
Clinical symptoms 
Adult cattle present no or mild clinical symptoms when infected with Schmallenberg virus 
(Hoffman et al., 2012; Van der Poel et al., 2013; Schulz et al., 2014). Symptoms are displayed 
for a brief period (days) and include fever, decreased milk yield and diarrhoea (Hoffman et al., 
2012; Van der Poel et al., 2013). There seems to be no difference in the course of infection 
between the genders (Wernike et al., 2013a). 
 
Experimentally infected sheep and goats usually do not display any clinical symptoms at all 
during viremia or later course of infection (Wernike et al., 2013b; Poskin et al., 2014; Poskin 
et al., 2015; Martinelle et al., 2015; Laloy et al., 2015). Some sheep show very mild clinical 
signs in the form of diarrhoea and snotty nose (Wernike et al., 2013b) and fever (Poskin et al., 
2014). 
 
Farmers in France retrospectively stated that they had seen a higher frequency of repeated 
oestrus and early embryonic death in their cattle, sheep and goats during the vector season of 
2012 when Schmallenberg virus spread in the country (Dominguez et al., 2014). 
 
Congenital Schmallenberg 
Transplacental infection with Schmallenberg virus can, but does not always, lead to abortion, 
stillbirth or malformations (Garigliany et al., 2012; Martinelle et al., 2015). If symptoms are 
expressed in the offspring, the most common ones are malformations such as arthrogryposis 
(joint deformity/contracture) and different malformations of the vertebral column and brain 
(Bayrou et al., 2014; Dominguez et al., 2014). Bayrou et al. (2014) found that Schmallenberg 
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virus infected calves had a significantly (on average 35 %) lower birth weight than unaffected 
calves, and stillbirths often occurred. A lower body weight at birth seems to be connected to 
more severe bodily malformations and a lower amount of skeletal muscles. 
 
When Schmallenberg virus spread in naïve populations in France during 2011-2013, there was 
a great variability in morbidity rate between herds. The average risk of deformities due to 
congenital Schmallenberg in offspring was 3 % in calves, 8 % in lambs and 2 % in goat kids 
(Dominguez et al., 2014). Martinelle et al. (2015) did not observe any signs of congenital 
Schmallenberg in any of the offspring to experimentally infected ewes, suggesting that the risk 
of congenital Schmallenberg is rather low, even if transplacental transmission has taken place. 
 
Prophylaxis 
To minimize the risk of congenital Schmallenberg, Statens Veterinärmedicinska Anstalt (2017) 
suggests exposure of young ruminants to Schmallenberg virus before they become sexually 
mature and breed. This is acquired by keeping them on pasture during vector season and letting 
them be naturally exposed to the vector and the virus, go through viremia and then seroconvert, 
i.e. acquire immunity. 
 
Another way of diminishing the risk of congenital Schmallenberg in temperate climates is to 
allow young sheep and goats to breed in the beginning of the vector free period, thus eliminating 
the risk of infection and transplacental transmission during the susceptible part of pregnancy 
(SVA, 2017). 
 
Vaccine 
The first vaccine against Schmallenberg virus in cattle and sheep came in 2013. It is called 
Bovilis® SVB and is an inactivated vaccine with adjuvants to boost the immune response (MSD 
Animal Health, 2013). Only non-pregnant animals should be injected with the vaccine. In cattle, 
two doses are administered four weeks apart and in sheep only one dose is necessary. Immunity 
is acquired after three weeks. In 2014 and 2015 two other inactivated vaccines with adjuvants 
also got approved on the European market (EMA, 2017; Merial, 2017). 
 
In Sweden, vaccine has been available since 2013 (SJV, 2017) but only by licence (SVA, 2017). 
It is not a general recommendation to vaccinate all animals in Sweden since the disease is 
considered endemic in the country, and hence does not provide a threat to production economics 
(SVA, 2017). 
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MATERIAL AND METHODS 
Literature review 
The database PubMed was used to search for relevant articles. Words used for search included, 
but were not limited to: Schmallenberg, midges, cattle, sheep, goats, transmission, 
Orthobunyavirus, Simbu. Many of the found articles also gave suggestions in their reference 
section about other relevant articles. 
 
Sample collection 
The blood samples were collected in the Gaza province, in the districts of Macia, Xai-Xai, 
Chibuto and Chokwe between 2014-10-22 and 2014-10-30 (Figure 1). The samples from Macia 
were collected in 2014-10-03 by a veterinary colleague at the Veterinary Faculty in Eduardo 
Mondlane University in Maputo. 
 
Blood samples 
In total, 730 blood samples were collected from seven farms in four different districts of the 
Gaza province. From cattle, 494 samples were collected, 77 from sheep and 159 from goats 
(Tables 1, 2 and 3). The vacutainer system was used for collecting the samples in EDTA 
collection tubes. The cattle samples were collected from the tail vein and samples from sheep 
and goats from the jugular vein on either side of the neck. The cattle were picked randomly and 
the quota of samples collected was approximately 25% of the cattle population on each farm. 
All genders and age (>4 months) were represented. Regarding the sheep and goats, almost all 
animals of both genders on each farm were included, except for very young animals (<6 weeks 
old) and some adult animals on Gogoti that managed to escape from their paddock before 
sampling could take place. The samples were stored in an ice box at approximately 4° C during 
transportation to the laboratory. 
 
FTA cards 
Some of the blood samples were put on FTA cards immediately after sampling. Due to a limited 
amount of FTA cards only samples from some of the farms were included. All cattle samples 
from Nguluzane and Bassopa were included and a few of the samples from Ndonga. All sheep 
and goat samples from Nguluzane and Bassopa were included and some of the samples from 
Psungo. After separating the serum fraction from the blood cells in the lab, the corresponding 
serum of each sample was also put on the FTA cards, which were shipped to Sweden for further 
analysis in other projects. 
 
Informal interviews 
During the sample collection, a veterinary colleague named Belisario Moiane asked the farmers 
and their staff questions about the history of disease on the farms. The questions were aimed to 
determine whether the farmer or staff had noticed any clinical symptoms, abortions, birth 
malformations or disturbances in the overall reproduction. 
 
  
10 
 
Table 1. Cattle blood samples with collection date, district of the farm, farm name, GPS coordinates 
and exact number of samples collected 
Date District Farm Coordinates No. of samples 
2014-10-03 Macia Macia Unknown 
 
98 
2014-10-22 Xai-Xai Nguluzane 25° 5’ 40,4” S 
33° 39’ 5,3” E 
50 
2014-10-25 Xai-Xai Bassopa 25° 00’ 59,1” S 
33° 33’ 48,0” E 
61 
2014-10-27 Guijá Ndonga 24° 21’ 12,5” S 
32° 52’ 31,1” E 
95 
2014-10-29 Chókwè Chalucuane 24° 44’ 15,5” S 
33° 24’ 56,2” E 
150 
2014-10-30 Chibuto Gogoti 24° 34’ 31,6” S 
33° 24’ 12,7” E 
40 
 
Table 2. Sheep blood samples with collection date, district of the farm, farm name, GPS coordinates 
and exact number of samples collected 
 
Table 3. Goat blood samples with collection date, district of the farm, farm name, GPS coordinates 
and exact number of samples collected 
Date District Farm Coordinates No. Of samples 
2014-10-22 Xai-Xai Nguluzane 24° 5’ 40,4” S 
33° 39’ 5,3” E 
66 
2014-10-24 Xai-Xai Bassopa 25° 00’ 59,1” S 
33° 33’ 48,0” E 
33 
2014-10-27 Guijá Ndonga 24° 21’ 12,5” S 
32° 52’ 31,1” E 
6 
2014-10-27 Guijá Psungo 24° 15’ 46,3” S 
32° 53’ 0,0” E 
10 
2014-10-30 Chibuto Gogoti 24° 34’ 31,6” S 
33° 24’ 12,7” E 
44 
 
 
Date District Farm Coordinates No. of samples 
2014-10-24 Xai-Xai Bassopa 25° 00’ 59,1” S 
33° 33’ 48,0” E 
51 
2014-10-27 Guijá Psungo 24° 15’ 46,3” S 
32° 53’ 0,0” E 
14 
2014-10-30 Chibuto Gogoti 24° 34’ 31,6” S 
33° 24’ 12,7” E 
12 
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Figure 1. Geographical locations of the farms in the Gaza province in Mozambique where the samples 
were collected. 1) Nguluzane, 2) Bassopa, 3) Ndonga, 4) Chalucuane, 5) Gogoti, 6) Psungo. Macia is 
not plotted due to unknown coordinates. The small square in the left bottom shows a zoomed-out view 
displaying the southernmost part of Mozambique with neighbouring countries. 
 
Lab analyses 
Sample preparation 
The EDTA tubes were centrifuged for a couple of minutes to separate the serum fraction. The 
serum was then poured into 1,5 or 2 ml tubes, labelled with sample number and stored at -20°C. 
 
ELISA 
A selection of samples was screened with a competitive ELISA designed to target antibodies 
directed against Schmallenberg virus nucleoprotein in cattle, sheep and goats. The kits came 
from ID Vet and is called “ID screen® Schmallenberg Virus Competition Multi-Species”. The 
instruction from the kits was followed and 50 μl undiluted serum was used in each well. Two 
positive and two negative controls (provided by the manufacturer) and two distilled water 
controls were included in every plate. The cut off values recommended by the manufacturer 
were used to determine the outcome. Unfortunately, there was no materials left to screen diluted 
serum from any of the positive samples as initially planned, hence, this was not done. 
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RNA extraction 
The materials and protocols used came from Thermo Scientific in a kit called “Thermo 
Scientific GeneJET RNA Purification Kit”. Protocol C, from the information included the kit, 
“C. Human Blood Cells Total RNA Purification Protocol” was used for the serum. The protocol 
was followed, except for the first step that was skipped. Instead 200 μl of serum was directly 
added to 600 μl of lysis buffer. The last step was also modified, and instead of using 50 μl 
nuclease free water and centrifuging at 1200 x g for one minute, 20 μl nuclease free water was 
used twice, with centrifuging in between and after, both at 1200 x g for one minute. The 
extracted RNA was then labelled properly and stored at -80° C. 
 
Spectrophotometry 
The total concentration (ng/µl) of extracted RNA in the samples was measured to determine to 
what extent the samples needed to be diluted to be suitable as template for real-time RT-qPCR 
(reverse transcription quantitative PCR). The system used was called NanoDrop1000 and came 
from Thermo Scientific. All concentrations <50 ng/µl was considered suitable for real-time RT-
qPCR without prior dilution. 
 
Pan Simbu real-time RT-qPCR 
Some of the eluted RNA from the serum samples was analysed with Pan Simbu real-time RT-
qPCR (Fischer et al., 2013). The materials used came from Thermo Fisher. 
 
PCR mastermix (15 µl): 
Express SuperScript qPCR SuperMix Universal   10 µl 
Forward primer panOBV-L-2959F (10 µM)   0,5 µl 
Reverse primer panOBV-L-3274R (10µM)   0,5 µl 
Express SuperScript Mix for one-step qPCR   2 µl 
DEPC-treated water     2 µl 
 
15 µl mastermix and 5 µl template RNA was used for each reaction. At least one negative 
control from the manufacturer was included in each run. The protocol used was a bit modified 
compared to the one stated by Fischer et al. (2013) and included the following steps: 
 
• 50° for 15 minutes 
• 95° for 2 minutes 
• 95° for 15 seconds 
• 55° for 1 minute 
• Repeat step three and four 40 times 
• Melting curve: from 55° C to 95° Celsius with an increase of 0.5° C every minute 
• 4° C forever 
 
The PCR-products were stored at -20° C and shipped to Sweden. 
 
Gel electrophoresis 
Gel electrophoresis was not a part of the original plan, but was used on one occasion to evaluate 
the results from one of the real-time RT-qPCR runs. The gel used was 2 % agarose gel and the 
dye added to the gel was called “GR green DNA stain”. 5 µl of the respective PCR product 
were mixed with 1 µl “DNA loading dye” and the mix was applied to the wells in the gel. The 
electrophoresis ran for 20 minutes at 80 V and the result was inspected visually under ultra 
violet light to determine the outcome. 
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cDNA synthesis 
Some of the samples with extracted RNA underwent first strand cDNA synthesis to make the 
product more stable and allow for shipping to Sweden and further analysis in other projects. 
The materials used came from Thermo Scientific in a kit called “Thermo Scientific Maxima H 
Minus Reverse Transcriptase”. The protocol from the kit was followed, including the optional 
step 2. The products were stored at -20° C until shipping. 
 
Possible sources of error 
• Pipette errors either because of uncalibrated pipettes or due to faulty pipetting 
• Unexpected power breakdowns during lab procedures and storage of the samples 
• Suboptimal temperatures for some of the reagents during shipping from Sweden to 
Mozambique that might have changed their properties  
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RESULTS 
Informal interviews 
None of the farmers or staff asked on the farms had noticed any clinical symptoms, elevated 
levels of abortions, birth malformations or disturbances in the overall reproduction during the 
weeks prior to the interviews. 
 
ELISA 
Four ELISA-plates were performed. In total, 328 serum samples were analysed, including 92 
cattle samples, 77 sheep samples and 159 goat samples. 
 
Cattle 
Since the total number of cattle samples was high (494 samples) a selection of 92 samples were 
tested with ELISA. 15-16 samples from each farm were randomly selected regardless of the 
age and gender of the animals. All farms showed a high percentage of cattle positive for 
Schmallenberg virus antibodies and in two cases, Macia and Gogoti, 100 % of the animals were 
seropositive (Table 4). The seroprevalence among all the tested animals was 90.2 % and the 
mean seroprevalence among the farms was 90.3 %. 
 
Sheep 
All 77 sheep samples were tested. All three farms had animals that tested positive with the 
highest seroprevalence on Gogoti, 91.7 % (Table 5). The seroprevalence among all tested sheep 
was 59.7 %, which is lower compared to the mean seroprevalence among the farms that was 
74.2 %. 
 
Goats 
All 159 goat samples were included in the ELISA. All farms had animals that tested positive 
(Table 6), but in one case, Ndonga, only one out of six (16.7 %) of the animals tested positive, 
while four (66.7 %) tested negative. The other farms all had at least ten animals tested and the 
second lowest proportion of positives was found on Bassopa, where 69.7 % of the animals were 
antibody positive. The highest percentage of positives was found at Psungo, where 90 % of the 
animals tested positive. The prevalence for the tested animals was 74.8 %, slightly higher than 
the mean prevalence among the farms that was 66.5 %. 
 
Spectrophotometry 
Most of the extracted RNA were analysed using spectrophotometry to determine if it needed 
dilution before being used as template for real-time RT-qPCR. The highest value measured was 
2,3 ng/µl from one of the cattle samples. All the other samples measured were in the range 0-
2,3 ng/µl, far below the 50 ng/µl limit. Samples from all three species were measured. Some 
samples were not tested due to lack of time and the expectancy that they also would be well 
below the limit for the need of dilution. 
 
Pan Simbu real-time RT-qPCR 
In total, 99 samples were analysed with Pan Simbu real-time RT-qPCR. All farms were 
represented, but not necessarily by all three species of animals. The chosen samples only came 
from animals showing a clearly positive result in the ELISA. All antibody positives were 
unfortunately not included due to a limited amount of reagents available for the PCR 
Mastermix.  
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Table 4. Proportion of cattle tested positive, doubtful or negative in Schmallenberg virus antibody 
specific competitive ELISA. Total number of tested samples presented to the right 
Farm Positive (%) Doubtful (%) Negative (%) No. of samples tested 
Macia 100 0 0 15 
Nguluzane 73.3 26.6 0 15 
Bassopa 93.3 6.7 0 15 
Ndonga 87.5 6.3 6.3 16 
Chalucuane 87.5 6.3 6.3 16 
Gogoti 100 0 0 15 
Total 90.2 % 7.6 % 2.2 % 92 
 
Table 5. Proportion of sheep tested positive, doubtful or negative in Schmallenberg virus antibody 
specific competitive ELISA. Total number of tested samples presented to the right 
Farm Positive (%) Doubtful (%) Negative (%) No. of samples tested 
Bassopa 45.1 35.3 19.6 51 
Psungo 85.7 7.1 7.1 14 
Gogoti 91.7 0 8.3 12 
Total 59.7 % 24.7 % 15.6 % 77 
 
Table 6. Proportion of goats tested positive, doubtful or negative in Schmallenberg virus antibody 
specific competitive ELISA. Total number of tested samples presented to the right 
Farm Positive (%) Doubtful (%) Negative (%) No. of samples tested 
Nguluzane 78.8 9.1 12.1 66 
Bassopa 69.7 12.1 18.2 33 
Ndonga 16.7 16.7 66.7 6 
Psungo 90 0 10 10 
Gogoti 77.3 0 22.7 44 
Total 74.8 % 6.9 % 18.2 % 159 
 
Cattle 
46 cattle samples from the farms Macia, Ndonga, Chaulucuane and Gogoti were analysed. All 
the tested samples were negative. 
 
Sheep 
37 sheep samples from the farms Bassopa, Psungo and Gogoti were analysed. All the tested 
samples were negative. 
 
Goats 
 16 goat samples from Nguluzane, Bassopa, Psungo, Ndonga and Gogoti were analysed. All 
the tested samples were negative. 
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Gel electrophoresis 
Since one run of real-time RT-qPCR yielded somewhat curious results, a gel electrophoresis 
was performed, including PCR products from 12 of the cattle samples. The samples were picked 
based on that they showed signs of some amplification during the real-time RT-qPCR. The gel 
showed only diffuse bands of short nucleic acids (<100 bp), see Figure 2 below. 
  
Figure 2. Gel showing only faint bands of short nucleic acids (<100 bp). From the left: Ladder (100 
bp), negative control, C435, C439, C449, C454, C574, C591, C692, C700, C708, C727, C732, C735.  
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DISCUSSION 
The results from the screening of Schmallenberg virus antibodies with competitive ELISA in 
the Gaza province of Mozambique are consistent with the results obtained by Blomström et al. 
(2014) from the Zambezia province. A clear majority of cattle, 90.2 % in the present study, 
compared to 100 % in Blomström et al. (2014), were ELISA positive in undiluted serum. The 
within-herd seroprevalence varied between 73.3 % and 100 % with a mean of 90.3 % in the 
present study and did not differ almost at all compared to the seroprevalence among all tested 
cattle (90.2 %). The study by Mathew et al. (2015) in Tanzania indicated a slightly lower 
seroprevalence in cattle screened by indirect ELISA, 61 % of the animals investigated were 
seropositive. 
 
Among sheep, the within-herd seroprevalence varied between 45.1 % and 91.7 %, with a mean 
of 74.2 %, in the present study. The seroprevalence of all tested sheep was 59.7 %. Blomström 
et al. (2014) reported a within-herd prevalence between 43 % and 97 %. 
 
In goats, the present study found a within-herd seroprevalence between 16.7 % and 90 %, with 
a mean of 66.5 %. Of all the goat samples, 74.8 % were positive. Blomström et al. (2014) 
reported a within-herd seroprevalence between 72 % and 100 % in goats of the Zambezia 
province in Mozambique. 
 
One of the farms, Ndonga, had only one out of six positive goat samples. This farm had a 
seroprevalence of 87.5 % in cattle. Unfortunately, no data concerning the age of the tested 
animals from any of the farms was available. Either most of the goats from Ndonga were too 
young or had for some other unknown reason not been exposed to the virus giving the positive 
ELISA result in cattle and in the single goat.  
 
None of the farmers in the informal interviews had noticed any clinical symptoms in their 
animals or any malformed offspring. This is also consistent with the findings of Blomström et 
al. (2014). If it truly is Schmallenberg virus causing the positive ELISA, vector activity is 
evenly distributed over the seasons and many of the animals will be infected before they breed, 
missing the period when transplacental transmission can occur (Garigliany et al., 2012; Bayrou 
et al., 2014; Martinelle et al., 2015). Transplacental transmission does not always cause 
congenital Schmallenberg (Garigliany et al., 2012; Martinelle et al., 2015). Also, very few 
animals per unit of time can be expected to show clinical disease if Schmallenberg virus is 
endemic in the area, and most animals that have gone through a previous infection have an 
immunity lasting for several years (Poskin et al., 2015; Wernike et al., 2015b). 
 
It is possible that the farmers either does not know what symptoms to look for in adult animals 
or that the animals are not as supervised as in European production facilities and the mild or 
even absent clinical symptoms in adult animals (Hoffman et al., 2012; Van der Poel et al., 2013; 
Wernike et al., 2013b; Poskin et al., 2014; Schulz et al., 2014; Poskin et al., 2015; Laloy et al., 
2015; Martinelle et al., 2015) can pass unnoticed. 
 
The question of which virus or viruses causing the positive ELISA results remains unanswered. 
Cross reactivity using indirect methods to detect viruses of the Simbu serogroup might occur 
(Abutarbush et al., 2015; Mathew et al., 2015), making it difficult to draw accurate conclusions. 
Many Simbu serogroup viruses circulate in Africa (Theodoridis et al., 1979; Zeller & Bouloy, 
2000; Mathew et al., 2015). It might be one or several of them that are responsible for the high 
percentage of positive ELISA results, since cross reactions cannot be excluded. On the contrary, 
they are rather probable. 
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Further studies to investigate the prevalence of Schmallenberg virus specific antibodies in 
different regions of Mozambique and southern Africa is of course of interest. Commercial 
ELISA kits might not be the best way to do this due to their unknown validity in areas where 
other viruses of the Simbu serogroup might circulate or even be endemic and due to the risk of 
cross reactivity with such viruses. Virus neutralization tests might be another option, since it is 
considered the most accurate and detailed of the indirect detection methods, but the problem 
with cross reactivity remains. It would however be possible to draw some conclusions if several 
Simbu serogroup viruses were included in such a study, since the titers for the different viruses 
would be obtained and could be compared. It is also of great interest to further investigate any 
chosen antibody detection method for cross reactions among the Simbu serogroup to achieve a 
greater understanding concerning this matter. 
 
To investigate the possibility of another virus causing the positive ELISA results, a Pan-Simbu 
real-time RT-qPCR was chosen for detection of viral RNA. All the Pan-Simbu real-time RT-
qPCR runs yielded negative results. This was perhaps due to the study design where only 
seropositive animals were used for PCR. The viremic period of Schmallenberg virus and of 
many other Simbu serogroup viruses is very short, only a few days (Van der Poel et al., 2013; 
Wernike et al., 2013a; Wernike et al., 2013b; Poskin et al., 2014; Schulz et al., 2014; Laloy et 
al., 2015; Martinelle et al., 2015; Poskin et al., 2015). When an animal has seroconverted, 
which happens at earliest at day 6-8 post infection with Schmallenberg virus (Wernike et al., 
2013a; Wernike et al., 2013b; Poskin et al., 2014; Schulz et al., 2014; Laloy et al., 2015), the 
viremic period has already ended in most animals. 
 
To try to find Schmallenberg viral RNA or RNA from another Simbu serogroup virus or viruses 
would be an interesting quest in future studies. This, however, can be very tricky to achieve. 
The chance of finding a viremic animal is very low due to the short viremia, even if great care 
is taken when choosing suitable animals. One option would be to screen very young animals 
with ELISA and only go through with PCR in seronegative or doubtful animals from farms 
with seropositive animals and hope to catch an animal with viremia. 
 
A viable way might be to try to isolate Schmallenberg virus from sperm of young, seropositive 
bulls, since Schmallenberg virus shedding can continue for 2-3 months after viremia has ended 
in some individuals. Great individual variation is seen though, virus shedding might be 
intermittent and the highest concentrations of viral RNA is seen during the first week of 
infection (Hoffman et al., 2013; Van der Poel et al., 2013; Ponsart et al., 2014). 
 
Another option would be to finance a surveillance program where farmers could be on the 
lookout for offspring with signs of congenital Schmallenberg and send them in for analysis 
when they occur. Midges could also be taken into consideration for trying to detect 
Schmallenberg or Simbu serogroup viral RNA, but this approach would need very many 
specimens to be included to have a chance to succeed. 
 
CONCLUSIONS 
Antibodies targeted against Schmallenberg virus or a similar virus circulate the Gaza province 
in Mozambique and can be found in cattle, sheep and goats. Viral RNA from Schmallenberg 
virus or any other Simbu serogroup virus has not yet been isolated from seropositive animals 
in the area. 
 
Further, carefully designed, studies need to be made to determine whether it truly is 
Schmallenberg virus or if it is another virus causing the positive ELISA results. 
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